Latest Commentary




The brokers might prefer RIO, but we think BHP’s broader mix of commodities, its diversification strategy and history of delivering shareholder returns, makes it the better buy of the two – but on..

Full Article >

Australian biotechnology is considered to be world class, but stocks in this sector can be risky business. Part 1 of this biotech series reveals four stocks to consider.

Full Article >